# PREcoopERA (NCT05896566)

> A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05896566
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: ETOP IBCSG Partners Foundation
- Conditions: Breast Cancer
- Interventions: Giredestrant; Triptorelin; Anastrozole
- Enrollment: 231
- Primary outcome: Change in Ki 67

## Commentary we found

- X threads: 11
- YouTube: 6
- Podcasts: 3
- X videos: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=precoopera-nct05896566

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05896566", "email": "<work email>"}; the inbox owner confirms by the emailed link.